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Abstract 
Introduction: Coronary heart disease and its risk factors depend on genetic characteristics, behaviors, and habits, all of which vary in different 
regions. The use of antiretroviral therapy (ARV) has increased the survival of people living with HIV/AIDS (PLWHA), who begin to present 
mortality indicators similar to the general population. This study aimed to compare the prevalence of factors potentially associated with 
coronary heart disease in three cohorts of PLWHA from three different regions of Brazil. 
Methodology: The study population was composed of participants of the cohorts of Pernambuco, Goiás, and Rio Grande do Sul states. In 
these sites, adult patients attending reference centers for treatment of HIV/AIDS were consecutively enrolled. 
Results: Pernambuco and Goiás had a higher proportion of males and of individuals with high-risk high-density lipoprotein (HDL). 
Pernambuco also had a greater proportion of individuals with hypertension, elevated triglycerides, and CD4 counts below 200 cells/mm3. 
Lower education was more frequent in Rio Grande do Sul, and the use of cocaine was higher in this state. 
Conclusions: The results confirm the importance of risk factors for coronary heart disease in PLHIV and highlight differences in the three 
cohorts. Specific measures against smoking and sedentary lifestyle, avoidance of advanced stages of immunosuppression, and appropriate 
treatment of dyslipidemia and dysglicemia are urgently needed to cope with the disease in Brazil. 
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Introduction 
Mortality rates among people living with 
HIV/AIDS (PLWHA) remain higher than those 
observed in the general population [1], despite the 
significant decline observed after the large-scale 
implementation of antiretroviral therapy (ARV) [2,3]. 
The concern goes beyond the early death of the 
patient, even in developing countries, and has been 
focusing on the adverse effects of ARV and co-
morbidities not related to HIV. The aging of HIV-
infected individuals has brought about the emergence 
of age-related diseases [4], gradually changing 
patterns of morbidity and mortality due to increasing 
incidence of noncommunicable diseases [5], with an 
emphasis on cardiovascular risk factors and coronary 
heart disease (CHD) [6]. 
The evidence indicates that the increasing 
prevalence of chronic diseases in this population is 
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related to the metabolic changes associated with the 
use of ARV and to the increased longevity of 
individuals [2]. With longer survival, PLWHA have 
become vulnerable to diseases that affect the general 
population. Vulnerability increases depending on 
lifestyle and risk behaviors such as smoking, 
alcoholism, and illicit drug use, as well as obesity [4]. 
As the mortality rate among PLWHA remains higher 
in comparison with the general population [1], further 
efforts are needed to identify and reduce the 
prevalence of risk factors associated with AIDS-
related mortality as well as mortality not related to 
AIDS. The latter is responsible for half of the deaths in 
some countries [5].  
Studies have reported a prevalence of dyslipidemia 
and other risk factors for cardiovascular disease in 
PLWHA ranging from 20% to 80% [7] both in 
developed and developing countries [8,9]. 
In Brazil, the mortality rate from CHD in the 
general population increased from 46.2 per 100,000 
inhabitants in 2000 to 52.4 per 100,000 inhabitants in 
2010. However, in 2010, the highest rate of mortality 
from ischemic heart disease was observed in the South 
(62/100,000 inhabitants), while the rates for the 
Midwest and Northeast were 42.6 and 44.9 per 
100,000, respectively [10]. As CHD and the associated 
risk factors depend on genetic characteristics, 
behavior, and lifestyle, they vary from region to 
region. With the use of ARVs (and the consequent 
decline in mortality from opportunistic diseases) and 
the increased survival of PLWHA, this population has 
begun to present specific mortality indicators similar 
to those of the general population. One would assume 
that the prevalence of CHD in PLWHA varies 
throughout regions of Brazil, especially if this 
prevalence depends more on traditional risk factors 
than on HIV-related factors. This study aimed to 
describe and compare the prevalence of factors 
potentially associated with coronary heart disease 
using baseline data of three well-established cohort 
studies of people living with HIV/AIDS in the 
Northeast, Midwest, and South regions of Brazil. 
 
Methodology 
A joint analysis was performed in the baseline data 
of three well-characterized cohort studies of 
HIV/AIDS patients living in three metropolitan areas 
of three Brazilian states: Pernambuco, Goias, and Rio 
Grande do Sul, located, respectively, in the Northeast, 
Midwest, and South of the country. Brazil is a 
continental country (8,500,000 km
2
) with striking 
socioeconomic and cultural differences among 
regions. The states vary not only in geographic 
location, but also in the Brazilian Human 
Development Index (IDHM). Rio Grande do Sul, 
located in the South, has an IDHM of 0.746, which 
reflects higher socioeconomic status and better 
distribution. The state of Goiás is located in the 
Midwest, has an IDHM of 0.735 and intermediate 
socioeconomic status. The state of Pernambuco, on the 
other hand, is located in the Northeast, and has a lower 
level of development, a wealth distribution with higher 
contrast, and an IDHM of 0.673 [11]. Studies were 
conducted in the capitals of those states, which have 
marked differences in the incidence of AIDS. Porto 
Alegre, capital of Rio Grande do Sul, has the highest 
rate of AIDS incidence (95 cases per 100,000 
inhabitants), being in first place in Brazil, while 
Recife, capital of Pernambuco, holds the eighth 
position (35.5 cases per 100,000), and Goiânia, capital 
of Goiás, is thirteenth (27.5 cases per 100,000 
inhabitants). As a whole, the incidence rate of AIDS in 
Brazil is 20.2 cases per 100,000 population [12]. The 
states of Pernambuco and Goiás predominantly present 
HIV subtypes B and F, whereas Rio Grande do Sul 
presents a predominance of subtype C, which is 
apparently more virulent and therefore more easily 
spread [13]. 
HIV-infected patients attending referral centers for 
treatment of HIV/AIDS were consecutively enrolled. 
In Recife, patients seen in two public hospitals 
(Hospital Universitario Oswaldo Cruz, from 
Universidade de Pernambuco, and Hospital Estadual 
Correia Picanço, from Health Secretariat of the state) 
were between 17 and 74 years of age. The enrollment 
in Goiania occurred in a public referral center for 
infectious diseases (Hospital das Clinicas da 
Universidade Federal de Goias), including patients 
between 20 and 75 years of age without clinical 
evidence of active opportunistic infections at baseline. 
In Porto Alegre, patients 18 years of age and older 
seen in one of the largest outpatient HIV/AIDS centers 
(Hospital Sanatorio Partenon, of the Health State 
Department) were included. In all studies, pregnant 
women, patients with mental retardation, and patients 
under restriction of freedom were excluded. Data 
collection was performed concurrently: 2007–2009 
(Recife), 2009–2011 (Goiania), and 2006–2008 (Porto 
Alegre). All research projects were approved by the 
institutional review boards of the institutions, which 
are accredited by the Office of Human Research 
Protections, and all participants signed informed 
consent forms.  
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Patients had standardized blood pressure and 
anthropometric measurements and were interviewed at 
the clinics using similar questionnaires regarding 
demographic and social data, lifestyle, habits, current 
medical treatments, HIV infection, and related 
diseases. Additional information on the use of 
antiretroviral medicine, history of HIV infection, CD4 
T-cell count and viral load were obtained from 
medical records. Central obesity was determined by 
waist circumference, measured in duplicate, and the 
average was categorized as ≥ 102/88 cm for men and 
women, respectively. Weight and height were obtained 
to calculate body mass index (kg/m
2
), and were 
classified into < 25, 25–29, or ≥ 30 kg/m
2
. In Porto 
Alegre, there were four standardized measurements of 
blood pressure in two visits, using an oscillometric 
monitor OMRON CP-705, (Bannockburn, USA), and 
blood pressure was classified based on the average. In 
Recife and Goiania, there were two and three 
measures of blood pressure, respectively, using a 
calibrated aneroid sphygmomanometer (WelchAllyn 
Tycos, Skaneateles Falls, USA), and either the average 
as ≥ 140/90 mmHg or the use of blood pressure 
lowering agents was used to determine hypertension. 
Blood samples were collected after 12 hours of fasting 
for assaying total cholesterol, high-density lipoprotein 
(HDL), triglycerides, and blood glucose. Laboratory 
tests were performed within approximately three 
months of the date of the interview. Altered values 
were considered triglycerides ≥ 150 mg/dL and HDL 
cholesterol < 40 (men) or < 50 mg/dL (women). 
Diabetes mellitus was diagnosed based on fasting 
glucose ≥ 126 or the use of anti-diabetic agents. 
Metabolic syndrome was characterized according to 
the National Cholesterol Education Program (NCEP-
ATPIII), and specific cutoffs were used for fasting 
glucose ≥ 100 mg/dL and blood pressure ≥ 130/85 
mmHg or use of lowering agents, respectively, to 
determine diabetes mellitus and hypertension [14] 
 
Statistical analysis 
The statistical analysis consisted of calculating the 
prevalence of each category of the selected variables 
(potential risk factors for CHD) and their respective 
95% confidence intervals. The frequencies of risk 
factors among datasets were compared using Chi-
square tests, and the means were compared by 
applying the t test for independent samples. 
 
Results 
Table 1 shows sociodemographic factors and 
lifestyle habits potentially associated with coronary 
heart disease in patients with HIV/AIDS, from three 
states, corresponding to different regions of Brazil. 
With respect to variables, a greater prevalence of 
individuals under 50 years of age was observed, and 
Table 1. Comparison of risk factors for coronary heart disease in persons living with HIV/AIDS in three Brazilian states, 
corresponding to different regions of the country 
 
Recife (Northeast) Goiania (Midwest) Porto Alegre (South) 
P value 
N % (95% CI) N % (95% CI) N % (95% CI) 
Patients 2,347 - 300 - 1,240 - - 
Sociodemographic data        
Age (years)       0.018 
< 40  1,237 52.7 (50.7–54.7) 181 60.3 (54.8–65.9) 711 57.4 (54.6–60.1)  
40–49  768 32.7 (30.8–34.6) 82 27.3 (22.2–32.4) 351 28.3 (25.8–30.8)  
50–59  282 12.0 (10.7–13.3) 27 9.0 (5.7–12.3) 138 11.1 (9.4–12.9)  
≥ 60  60 2.6 (1.9–3.2) 10 3.3 (1.3–5.4) 40 3.2 (2.2–4.2)  
Male sex 1,467 62.5 (60.5–64.5) 230 76.7 (71.9–81.5) 628 50.6 (47.9–53.4) < 0.001 
Years of schooling       < 0.001 
Illiterate 269 11.6 (10.3–12.9) 6 2.0 (0.4–3.6) 40 3.2 (2.2–4.2)  
1–9 1,098 47.4 (45.3–49.4) 97 32.3 (27.0–37.7) 795 64.1 (61.4–66.8)  
10–12 688 29.7 (27.8–31.5) 114 38.0 (32.5–43.5) 279 22.5 (20.2–24.8)  
≥ 12  263 11.3 (10.0–12.6) 83 27.7 (22.6–32.8) 126 10.2 (8.5–11.8)  
Lifestyle habits        
Abusive use of alcohol  534 22.8 (21.1–24.5) 71 26.3 (21.0–31.6) 69 5.6 (4.3–6.8) < 0.001 
Current smoker 572 24.4 (22.7–26.1) 69 23.0 (18.2–27.8) 525 42.3 (39.6–45.1) < 0.001 
Physical activity: > 150 
min/week 
498 21.2 (19.6–22.9) 77 25.7 (20.7–30.6) 664 53.5 (50.8–56.3) < 0.001 
Lifetime use of crack 159 6.8 (5.8–7.8) - - 111 8.9 (7.4–10.5) 0.019 
Lifetime use of cocaine  210 9.0 (7.8–10.1) 32 10.7 (7.1–14.2) 367 29.6 (27.1–32.1) < 0.001 
Hypertension 693 29.5 (27.7–31.4) 60 20.0 (15.4–24.6) 241 19.4 (17.2–21.6) < 0.001 
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patients from the three settings had differences in age 
distribution. While in the South there was a lower 
proportion of males, in the Midwest, males 
represented three-quarters of the population. The study 
population had a heterogeneous education level, with a 
higher proportion of individuals with less education 
(up to 9 years of study) in the South and a higher 
proportion of individuals with more education (12 
years or more) in the Midwest. In relation to lifestyle 
habits, it was observed that alcohol abuse was less 
frequent in in the South, while the proportion of 
current smokers was larger. There was a marked 
difference in the use of cocaine among patients from 
the three states, with higher consumption in Porto 
Alegre and lower consumption in Recife. Participants 
from Recife and Goiania were more sedentary. 
Hypertension was prominent in the Northeast.  
Regarding the characteristics related to HIV, the 
Northeast had the highest proportion of participants 
taking antiretroviral agents and, on average, for a 
greater length of time; however, these patients had 
lower CD4 counts (< 200 cells/mm
3
) (Table 2). 
Obesity was more prevalent in the South, while 
normal abdominal circumference was more frequent in 
the Northeast.  
With respect to metabolic profiles, Table 3 shows 
that diabetes mellitus was more prevalent in the South, 
high triglycerides in the Northeast, and abnormal 
cholesterol in the Midwest. Prevalence of metabolic 
syndrome varied markedly between Recife and Porto 
Alegre, while the point estimate for Goiania had a 
wider confidence interval. Framingham score (mean) 
was higher in the Northeast. 
Among PLWHIV with metabolic syndrome, there 
was a trend to increased enlarged abdominal 
circumference from the Northeast to the South. In the 
Midwest, triglycerides were higher and fasting glucose 
was lower, while abnormal HDL cholesterol was 
lower in the South (Table 4).  
 
Discussion 
In this analysis, differences in demographic 
characteristics, socioeconomic status, lifestyle habits, 
HIV-related factors, anthropometric measurements, 
diabetes mellitus, hypertension, and lipid profiles of 
the PLWHIV from Northeast, Midwest, and South 
Brazil emerged, which were able to express distinct 
behaviors of the HIV infections. This is the first 
Brazilian study to detail cardiovascular risk factors in 
a relatively large population of PLWHIV and to 
compare data from regions where the disease 
incidence is increasing and about which information is 
scarce. 
Table 2. Comparison of HIV-related and anthropometric measurements associated with coronary heart disease in persons 
living with HIV/AIDS in three Brazilian states, corresponding to different regions of the country 
 
Recife (Northeast) Goiania (Midwest) Porto Alegre (South) P value 
N % (95% CI) N % (95% CI) N % (95% CI)  
Related to HIV        
Use of ARV 1,776 75.7 (73.9–77.4) 200 66.7 (61.3–72.0) 815 65.7 (63.1–68.4) < 0.001 
Time on ARV (mean SD) 4.4  3.5 years 2.7  2.5 years 3.8  2.8 years < 0.001
† 
CD4 (cells/mm3)       < 0.001 
< 200 345 20.0 (18.2–21.9) 26 8.9 (5.6–12.2) 181 14.8 (12.8–16.8)  
200–349 398 23.1 (21.1–25.1) 54 18.6 (14.1–23.0) 295 24.1 (21.7–26.5)  
350–499 396 21.0 (21.0–25.0) 66 22.7 (17.8–27.5) 317 25.9 (23.4–28.3)  
> 500 582 33.8 (31.6–36.1) 145 49.8 (44.0–55.6) 432 35.3 (32.6–37.9)  
Viral load  (copies/mL)       0.005 
< 400 603 53.8 (50.9–56.7) 161 55.7 (49.9–61.5) 616 50.4 (47.6–53.2)  
400–100,000 409 36.5 (33.7–39.3) 115 39.8 (34.1–45.5) 512 41.8 (39.1–44.6)  
> 100,000 109 9.7 (8.0–11.5) 13 4.5 (2.1–6.9) 93 7.7 (6.2–9.2)  
Anthropometric measurements        
Body mass index       < 0.001 
Eutrophic 1,597 69.2 (67.3–71.0) 188 67.9 (62.3–73.4) 709 57.2 (57.2–60.0)  
Overweight 552 23.9 (22.2–25.6) 74 26.7 (21.5–32.0) 379 30.6 (28.0–33.1)  
Obese 160 6.9 (5.9–8.0) 15 5.4 (2.7–8.1) 152 12.3 (10.4–14.1)  
Abdominal circumference       0.003 
Normal 1,525 65.0 (63.1–67.0) 172 57.3 (51.7–63.0) 737 59.4 (56.7–62.2)  
Enlarged 399 17.0 (15.5–18.5) 56 18.7 (14.2–23.1) 244 19.7 (17.5–21.9)  
Considerably enlarged 421 18.0 (16.4–19.5) 72 24.0 (19.1–28.9) 259 20.9 (18.6–23.2)  
† Bonferroni test: Statistically significant differences among regions 
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  Table 3. Comparison of metabolic profile associated with coronary heart disease in persons living with HIV/AIDS in three 
Brazilian states, corresponding to different regions of the country 
 Recife (Northeast) Goiania (Midwest) Porto Alegre (South) 
P value 
 N % (95% CI) N % (95% CI) N % (95% CI) 
Diabetes mellitus       < 0.001 
Normal 1,983 95.2 (94.3–96.2) 292 97.3 (95.5–99.2) 1,126 91.5 (90.0–93.1)  
Diabetes 99 4.8 (3.8–5.7) 8 2.7 (0.8–4.5) 104 8.5 (6.9–10.0)  
Metabolic syndrome 554 27.5 (25.6–29.5) 52 18.6 (14.0–85.9) 187 15.3 (13.2–17.3) < 0.001 
Laboratory tests        
Total cholesterol       < 0.001 
Normal 1,465 70.9 (68.9–72.9) 283 94.3 (91.7–97.0) 845 68.9 (66.3–71.5)  
Borderline 392 17.3 (17.3–20.7) 12 4.0 (1.8–6.2) 237 19.3 (17.1–21.5)  
High risk 209 10.1 (8.8–11.4) 5 1.7 (0.2–3.1) 144 11.7 (9.9–13.6)  
HDL-cholesterol       < 0.001 
Normal 515 21.9 (20.3–23.6) 29 9.7 (6.3–13.0) 306 24.7 (22.3–27.1)  
Borderline 936 39.9 (37.9–41.9) 170 56.7 (51.0–62.3) 685 55.2 (52.4–58.0)  
High risk 896 38.2 (36.2– 40.1) 101 33.6 (28.3–39.0) 249 20.1 (17.8–22.3)  
LDL-cholesterol       0.097 
Normal 1,489 79.3 (77.5–81.1) 247 85.5 (81.4–89.6) 967 78.9 (76.6–81.2)  
Borderline 265 14.1 (12.5–15.7) 32 11.1 (7.4–14.7) 171 13.9 (12.0–15.9)  
High risk 124 6.6 (5.5–7.7) 10 3.5 (1.3–5.6) 87 7.1 (5.7–8.5)  
Triglycerides       < 0.001 
Normal 1,077 52.0 (49.9–54.2) 189 63.0 (57.5–68.5) 787 64.2 (61.5–66.9)  
Altered 439 48.0 (45.8–50.1) 111 37.0 (31.5–42.5) 439 35.8 (33.1–38.5)  
Use of hypolipidemic agents 49 2.1 (1.5–2.7) 6 2.0 (0.4–3.6) 29 2.3 (1.5–3.2) 0.5 
Framingham score (mean ± 
SD) 
1,985 4.28 ± 6.10 300 3.42 ± 6.38 1,228 3.07 ± 7.82 < 0.001† 




Table 4. Distribution of metabolic syndrome components among persons living with HIV/AIDS with metabolic syndrome in 
three Brazilian states, corresponding to different regions of the country 
 
Recife (Northeast) Goiania (Midwest) Porto Alegre (South) 
P value 
N % (95% CI) N % (95% CI) N % (95% CI) 
Enlarged abdominal circumference 253 45.7 (41.5–49.8) 29 55.8 (41.8–69.7) 131 62.1 (55.5–68.6) < 0.001 
Triglycerides > 150 mg/dL 471 85.0 (82.0–88.0) 50 96.1 (90.7–100) 170 80.6 (75.2–86.0) 0.03 
Abnormal HDL-cholesterol 481 86.8 (84.0–89.6) 48 92.3 (84.8–99.8) 137 64.9 (58.4–71.4) < 0.001 
Hypertension 384 69.3 (65.5–73.2) 41 78.8 (67.4–90.3) 131 62.1 (55.5–68.7) 0.3 
Fasting glucose > 100 mg/dL 247 44.6 (40.4–48.7) 10 19.2 (8.2–30.3) 81 43.3 (36.1–50.5) 0.002 
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Although the South has the highest level of 
education [15] and income [16] among the three states, 
most PLWHA with less education belonged to this 
population. Considering that these participants reflect 
the overall HIV-infected patients, the results suggest 
that the process of pauperization of infection is more 
marked in the South. In those three states, although the 
rate of men to women is similar in the general 
population [17], both the results of this study and the 
data reported in the notification database (SINAN) 
(Pernambuco: 1.54, Goias: 1.83, Rio Grande do Sul: 
1.26) [18] point to a lower male/female ratio in the 
state of Rio Grande do Sul, suggesting that in the 
South, the feminization of the infection is more 
advanced. Differences in sociodemographic 
characteristics may convert into differences in the risk 
of CVD. Previous studies in the South indicated an 
association between fewer years of schooling and 
metabolic syndrome in men [19]. In the Northeast, an 
association between male sex and subclinical 
atherosclerosis [20] and higher velocity of pulse wave 
was observed, similar to the observations among HIV-
negative individuals [21]. 
In Brazil, the prevalence of smoking has been 
reduced in the last decades, but it is still higher among 
those with little or no education. In general, cities in 
the North and Northeast present lower than average 
rates [22]. Large cities located in the South and 
Southeast regions present higher prevalence rates, and 
Porto Alegre had the highest prevalence rate in the 
country among women. The prevalence of smoking in 
the South (42.3%) is similar to smoking rates among 
PLHIV in Europe [23], ranging from 40% to 50%, 
while the prevalence of smoking in Pernambuco and 
Goiás was lower, reflecting a lower prevalence of 
smoking in the Northeastern and Midwest regions 
(about 15% in the young adult population). All 
prevalence rates of smoking were higher among 
PVHIV than in the general population of the 
respective states. In addition, in Recife, the use of 
crack was found to be associated with the irregular use 
of ARV agents [24], which has implications in the 
spread of the infection besides CHD. 
With regard to HIV infection, CD4 counts below 
200 cells/mm
3
 were higher in Recife than in the other 
two cities, which may reflect delayed access to 
diagnosis and treatment in the Northeast. Grangeiro et 
al. [25], analyzing the data of approximately 100,000 
HIV-infected individuals who entered into care in 
Brazil between 2003 and 2006, detected a greater risk 
of a late entry into HIV care in the Northeast and 
Midwest in comparison to the South. 
Differences in metabolic risk factors, which may 
reflect the atherogenic profile, described for PLWHIV 
living in Recife were associated with high 
cardiovascular risk [26,27]. A previous study in Recife 
demonstrated an increased prevalence of 
hyperapolipoprotein B, which was associated with 
prolonged use of antiretroviral therapy, 
hypertriglyceridemia, insulin resistance, diabetes, and 
a past history of hypertension; hyperapolipoprotein B 
was higher among patients with metabolic syndrome 
and higher Framingham scores [28]. Interestingly, in 
the Rio Grande do Sul group, there was a higher 
proportion of overweight and obese individuals than in 
the other two states, although there was a smaller 
proportion of individuals with metabolic syndrome. 
The differences in lipid profiles were reflected in the 
components of metabolic syndrome in the participants 
of each study. 
In PLWHIV treated with antiretroviral agents, 
there is a marked increase in insulin resistance and 
diabetes mellitus prevalence [29-31], which is more 
common in ethnic minorities than in the white 
population [32,33]. In addition, chronic inflammation 
seems to influence the progression to diabetes in HIV-
infected patients. Chronic inflammation in HIV is 
evidenced by the elevation of systemic inflammatory 
markers [34]. The frequency of diabetes in the 
PLWHIV in this study was not higher than those 
reported to the general population in the same settings 
[35]. Data from Rio Grande do Sul showed diabetes as 
one of the strongest predictors of CHD risk in 10 years 
in PLWHIV [36]. 
Several alternatives may explain the differences in 
the lipid profiles in these PLWHIV. The use of lipid-
lowering therapy was low and similar among centers, 
but no dietary intervention had been provided, even 
though there is evidence of benefit equivalent to lipid-
lowering agents [37]. Although the frequency of 
physical inactivity was much higher in Recife, the 
effectiveness of physical activity in improving the 
lipid profile in HIV-infected patients in routine 
conditions is still unclear [38]. 
A possible explanation could be related to the 
ARV treatment. Although a higher proportion of 
patients were on highly active antiretroviral therapy 
(HAART) in Pernambuco and the length of time on 
treatment was higher, the differences were not large. 
The type of antiretroviral regimen employed, an 
alternative explanation, was not assessed in this study; 
however, because antiretroviral treatment is distributed 
equitably by the Brazilian Health Ministry, which has 
a specific protocol recommendation for the whole 
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country [39], there is no reason to suppose that there 
were great differences between the treatment regimens 
within the three study sites. This point deserves further 
investigation. Finally, one aspect to be considered is 
that in the state of Pernambuco, where patients 
presented higher levels of immunosuppression, 
represented by lower levels of CD4, dyslipidemia was 
more frequent. This association, if real, could be 
related to the degree of inflammation and the level of 
circulating cytokines. Analysis of a subsample of the 
Pernambuco cohort showed an association between 
high TNF-α levels and having attained a viral load ≥ 
100,000 RNA copies/mL and between IL-6 and a 
current CD4 level < 200 cells/mm3 [40]. The 
cytokines IL-6 and TNF-α and C-reactive protein have 
been reported to be higher in PLHIV and in those with 
previously severe immunosuppression [41], and they 
are related to the development of atherosclerosis, 
CHD, immunosenescence, and mortality due to non-
HIV-associated co-morbidities [42].  
We are aware that comparative studies like ours 
have inherent limitations. One concern would be about 
the representativeness of the studied population in 
each setting. In all settings, patients were equally 
enrolled in studies in reference centers for HIV/AIDS 
treatment. In Brazil, all HIV/AIDS patients are treated 
in the public sector with similar access to treatment 
throughout the country. Therefore, we may assume 
that the reference centers give assistance to patients of 
different socioeconomic levels and that the assembled 
patients may reflect the characteristics of the infected 
individuals in each setting. The lack of comparative 
data of risk factors for cardiovascular diseases among 
individuals with no HIV infection makes it difficult to 
judge to which extent the observed differences across 
the states reflect the distribution of these factors 
among the general population. However, it was 
beyond the scope of this study to assess risk factors for 
cardiovascular disease among individuals with no HIV 
infection; furthermore, these kind of data are not 
available nationwide. The selected risk factors herein 
analyzed were the classical ones, and information 
about other additional factors such inflammatory 
markers was not available for the three settings. One 
of the strengths of our analysis is that data on risk 
factors were collected using standardized 




The data presented herein confirm the importance 
of risk factors for CHD in the population of PLWHIV. 
This risk is even higher in the poorest individuals and 
in individuals who have reached a higher degree of 
immunosuppression. Specific measures against 
smoking and a sedentary lifestyle, the avoidance of 
advanced stages of immunosuppression, and actions to 
increase the awareness of cardiologists, 
endocrinologists, and nutritionists to provide 
appropriate treatment for dyslipidemia, dysglicemia, 
and hypertension in special assistance programs are 
urgently required and must be integrated into the 
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